Home › Mallinckrodt Launches Additional Dosage Strengths Of Generic CONCERTA In U.S
 

Keywords :   


Mallinckrodt Launches Additional Dosage Strengths Of Generic CONCERTA In U.S

2013-03-25 09:30:00| drugdiscoveryonline News Articles

Mallinckrodt, the Pharmaceuticals business of Covidien, recently announced that it launched the 36 and 54 milligram (mg) dosage strengths of Methylphenidate HCl Extended-Release (ER) Tablets USP (CII), generic version of CONCERTA

Tags: us additional generic strengths

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
09.10Hurricane Milton Public Advisory Number 15A
09.10Atlantic Tropical Weather Outlook
09.10Amount UK's richest pay in income tax revealed
09.10Eastern North Pacific Tropical Weather Outlook
09.10Hurricane Milton Potential Storm Surge Flooding Map
09.10Brazil gives Elon Musk's X green light for return
08.10Hurricane Milton Update Statement
08.10Summary for Hurricane Milton (AT4/AL142024)
More »